Teladoc Turns Smartphone Cameras Into AI-Powered Vital Sign Monitors
Teladoc Health adds AI tools SoloVitals and SoloScribe to its Solo platform to streamline hospital workflows and remote care.
Stocks · News reference
Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5
Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $11 to $7.5.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Teladoc Health Adds Two New AI-Powered Capabilities To Its Enterprise Smart Care Platform Solo
SoloVitals and SoloScribe are designed to help health systems bring timely patient insights into the care environment, while reducing technology fragmentation and helping care teams stay focused on patient
8-K filing — Teladoc Health, Inc. (TDOC)
Filed: 2026-09-25 AccNo: 0001477449-26-000046 Size: 176 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
OpenAI Announces MentalHealthBench, Open Benchmark For Evaluating AI Responses In Mental Health Conversations, Built With More Than 80 Licensed Experts
https://openai.com/index/introducing-mentalhealthbench/